Practical implications of in vitro stability of cardiac markers

Annals of Clinical Biochemistry

Volumn 38, Issue 1, 2001, Pages 61-63

  Woltersdorf, W W W ^a   Bayly, G R ^a   Day, A P ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CELL MARKER; CREATINE KINASE; CREATINE KINASE MB;

ARTICLE; CLINICAL FEATURE; DEVICE; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; HEART INFARCTION; HEART INJURY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS;

ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD PROTEINS; CARDIOMYOPATHIES; CREATINE KINASE; CREATINE KINASE, MB FORM; ENZYME STABILITY; HUMANS; ISOENZYMES; MASS SCREENING; TROPONIN I; TROPONIN T;

EID: 0035172648     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011900146     Document Type: Article

References (5)

1. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes
2. Creatine kinase isoforms: Investigation of inhibitors of in vitro degradation and establishment of a reference range
3. Degradation of cardiac troponin I: Implication for reliable immunodetection
4. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays
5. Antibody selection for the Abbott AxSYM Troponin I assay